Cited by 150Per- and polyfluoroalkyl substances researchToxic Organic Pollutants ImpactFluorine in Organic Chemistry

Perfluorooctanoate and Perfluorooctanesulfonate Plasma Levels and Risk of Cancer in the General Danish Population

Eriksen, K. T., Sorensen, M., McLaughlin, J. K., Lipworth, L., Tjonneland, A., Overvad, K., Raaschou-Nielsen, O.·2009·JNCI Journal of the National Cancer Institute

Abstract

Perfluorooctanoate and perfluorooctanesulfonate are used in many industrial products and have been widely detected in human blood. Both chemicals are associated with tumor development in animal studies, but data on carcinogenic potential in humans are sparse. We investigated the association between plasma levels of perfluorooctanoate and perfluorooctanesulfonate and cancer risk within a prospective Danish cohort of participants with no previous cancer diagnosis at enrollment. From enrollment, between December 1, 1993, and May 31, 1997, and through July 1, 2006, we identified 713 participants with prostate cancer, 332 with bladder cancer, 128 with pancreatic cancer, and 67 with liver cancer in the entire cohort and we selected a comparison subcohort of 772. Plasma concentrations of perfluorooctanoate and perfluorooctanesulfonate were measured in each participant by use of high-pressure liquid chromatography coupled to tandem mass spectrometry. We found no clear differences in incidence rate ratios for these cancers in relation to plasma concentrations of perfluorooctanoate or perfluorooctanesulfonate. A 30%-40% increase in risk estimates for prostate cancer was observed for the three upper quartiles of perfluorooctanesulfonate concentration compared with the lowest quartile (eg, for the lowest vs the fourth quartile, incidence rate ratio = 1.38, 95% confidence interval = 0.99 to 1.93). Plasma concentrations of perfluorooctanoate and perfluorooctanesulfonate in the general Danish population appear not to be associated with risk of prostate, bladder, pancreatic, or liver cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djp041

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Only studies by Eriksen et al. and Hardell et al. showed a statistically significant association between PFC concentration and prostate cancer.

    “Only studies made by Eriksen et al. and Hardell et al. showed statistical significant association between PFC concentration and prostate cancer [17, 20].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. Olsen GW , Burris JM , Ehresman DJ , et al . Half-life of serum elimination of perfl uorooc- tanesulfonate, perfl uorohexanesulfonate, and perfl uorooctanoate in retired fl uorochemical production workers . Environ Health Perspect . 2007 ; 115 ( 9 ): 1298 -1305 .
  2. Kennedy GL Jr , Butenhoff JL , Olsen GW , et al . The toxicology of perfl uorooctanoate . Crit Rev Toxicol . 2004 ; 34 ( 4 ): 351 -384 .
  3. Alexander BH , Olsen GW , Burris JM , Mandel JH , Mandel JS . Mortality of employees of a perfl uorooctanesulphonyl fl uoride manufac- turing facility . Occup Environ Med . 2003 ; 60 ( 10 ): 722 -729 .
  4. Alexander BH , Olsen GW . Bladder cancer in perfl uorooctanesulfonyl fl uoride manufactur- ing workers . Ann Epidemiol . 2007 ; 17 ( 6 ): 471 -478 .
  5. Gilliland FD , Mandel JS . Mortality among employees of a perfl uorooctanoic acid produc- tion plant . J Occup Med . 1993 ; 35 ( 9 ): 950 -954 .
  6. Ehresman DJ , Froehlich JW , Olsen GW , Chang SC , Butenhoff JL . Comparison of human whole blood, plasma, and serum matri- ces for the determination of perfl uorooctane- sulfonate (PFOS), perfl uorooctanoate (PFOA), and other fl uorochemicals . Environ Res. 2007 ; 103 ( 2 ): 176 -184 .
  7. Hornung RW , Reed LD . Estimation of aver- age concentration in the presence of nonde- tectable values . Appl Occup Environ Hyg . 1990 ; 5 ( 1 ): 46 -51 .
  8. Grambsch PM , Therneau TM . Proportional tests and diagnostics based on weighted resid- uals . Biometrika . 1994 ; 81 ( 3 ): 515 -526 .

Cited by

Sorted by citations

Authors
Eriksen, K. T., Sorensen, M., McLaughlin, J. K., Lipworth, L., Tjonneland, A., Overvad, K., & Raaschou-Nielsen, O.
Affiliations
Aarhus University Hospital (DK)
Venue
JNCI Journal of the National Cancer Institute
Published
2009-04-07
Volume
101
Issue
8
Pages
605-609
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2098197528
Cited by
150
References
25
Citations by year
2026: 13 · 2025: 15 · 2024: 17 · 2023: 12 · 2022: 14 · 2021: 11 · 2020: 7 · 2019: 2 · 2018: 6 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 7
FWCI
4.06
Type
journal article
Language
en
Open access
closed
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
3M
Topics
  • Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Fluorine in Organic Chemistry
Keywords
perfluorooctanoic acid, PFOS, perfluorinated compounds, plasma concentration, cancer risk, prostate cancer, bladder cancer, pancreatic cancer, liver cancer, prospective cohort, carcinogenicity, biomarkers of exposure
MeSH terms
Aged, Analysis of Variance, Urinary Bladder Neoplasms, Caprylates, Chromatography, High Pressure Liquid, Denmark, Environmental Pollutants, Female, Fluorocarbons, Humans, Liver Neoplasms, Male, Middle Aged, Neoplasms, Pancreatic Neoplasms, Prospective Studies, Prostatic Neoplasms, Risk Factors, Cohort Studies, Incidence, Odds Ratio, Alkanesulfonic Acids, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review